| Description |
Recombinant Human ST3GAL4 Protein is expressed from HEK293 with His tag at the C-Terminus and HA at the N-Terminus.It contains Glu41-Phe333. |
| Purity |
> 95% as determined by Tris-Bis PAGE |
| Accession |
Q11206.1 |
| Target Symbol |
ST3GAL4 |
| Synonyms |
Sialyltransferase 4C; SIAT4; SIAT4C; SIAT4-C; ST3Gal IV; ST3GAL4; ST3GalA.2; ST-4; STZSIAT4; Alpha 2,3-ST 4; CGS23; CGS23FLJ46764; FLJ11867; Gal-NAc 6S; NANTA3; SAT3; SAT-3 |
| Species |
Human |
| Expression System |
HEK293 |
| Tag |
N-HA,C-His |
| Expression Range |
Glu41-Phe333 |
| Mol. Weight |
The protein has a predicted MW of 35.4 kDa. Due to glycosylation, the protein migrates to 48-53 kDa based on Tris-Bis PAGE result. |
| Form |
Lyophilized |
| Formulation |
Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
| Endotoxin |
Less than 1EU per ug by the LAL method. |
| Storage |
Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
| Shipping |
Shipped at ambient temperature. |
| Gene Background |
ST3GAL4 gene expression is altered in different cancer types, including cervical cancer. Several mRNA transcripts have been reported for this gene. ST3GAL4 encodes for β‑galactosidase α‑2,3‑sialyltransferase 4, involved in the biosynthesis of the tumour antigens sLe(x) and sulfo‑sLe(x). |
